Table 1 Univariate analyses of different tumor stages and grades for OS in GC patients.
From: The involvement of collagen family genes in tumor enlargement of gastric cancer
Variables | n (%) | HR (95% CI) | P |
|---|---|---|---|
T stage | |||
T1 | 18 (4.83%) | 1 (Reference) | Â |
T2 | 74 (19.84%) | 6.475 (0.878–47.746) | 0.067 |
T3 | 161 (43.16%) | 9.467 (1.314–68.195) | 0.026 |
T4 | 95 (25.47%) | 9.772 (1.343–71.121) | 0.024 |
Not available | 25 (6.70%) | Â | Â |
N stage | |||
N0 | 104 (27.88%) | 1 (Reference) | Â |
N1 | 95 (25.47%) | 1.560 (0.969–2.512) | 0.067 |
N2 | 71 (19.03%) | 1.472 (0.871–2.487) | 0.149 |
N3 | 71 (19.03%) | 2.430 (1.506–3.923) | 0.0003 |
Not available | 32 (8.58%) | Â | Â |
M stage | |||
M0 | 314 (84.18%) | 1 (Reference) | Â |
M1 | 22 (5.9%) | 2.389 (1.346–4.242) | 0.003 |
Not available | 37 (9.92%) | Â | Â |
TNM Stage | |||
Stage I | 48 (12.87%) | 1 (Reference) | Â |
Stage II | 110 (29.49%) | 1.629 (0.825–3.215) | 0.160 |
Stage III | 145 (38.87%) | 2.294 (1.207–4.358) | 0.011 |
Stage IV | 34 (9.12%) | 4.080 (1.977–8.421) | 0.0001 |
Not available | 36 (9.65%) | Â | Â |
Grade | |||
G1 | 9 (2.41%) | 1 (Reference) | Â |
G2 | 126 (33.78%) | 1.648 (0.400–6.790) | 0.489 |
G3 | 208 (55.76%) | 2.140 (0.527–8.699) | 0.287 |
Not available | 30 (8.04%) | Â | Â |
